Chris Greeno

Chris holds a BA in Biology and Economics from Williams College and an MBA in healthcare management from The Wharton School.

Chris is a technology-driven investment professional focused on venture and growth-stage investments in life sciences and medtech. Currently, Chris is an Investment Director at Asahi Kasei’s corporate venture capital fund, leading investment strategy, diligence, and portfolio management for AK’s therapeutics and medical device focused funds. Where Chris shines is in conversations with physicians, founders, and researchers, connecting the dots between patient unmet need, technological capability, commercial opportunity, and corporate strategy.

​

Prior to AK, Chris worked in life sciences strategy consulting and biotech business development and founded and sold a small consumer business in Boston, MA.